A semi-qualitative study of attitudes to vaccinating adolescents against human papillomavirus without parental consent
- PMID: 17291343
- PMCID: PMC1804267
- DOI: 10.1186/1471-2458-7-20
A semi-qualitative study of attitudes to vaccinating adolescents against human papillomavirus without parental consent
Abstract
Background: The first vaccine to prevent human papillomavirus (HPV) and cervical cancer has been licensed, and in future, vaccination may be routinely offered to 10-14 year old girls. HPV is a sexually transmitted virus and some parents may refuse consent for vaccination. Under-16s in the UK have a right to confidential sexual health care without parental consent. We investigated parents' views on making available HPV vaccination to adolescent minors at sexual health clinics without parental consent.
Methods: This was a semi-qualitative analysis of views of parents of 11-12 year old school children collected as part of a population-based survey of parental attitudes to HPV vaccination in Manchester. Parents were firstly asked if they agreed that a well-informed child should be able to request vaccination at a sexual health clinic without parental consent, and secondly, to provide a reason for this answer. Ethical perspectives on adolescent autonomy provided the framework for descriptive analysis.
Results: 307 parents answered the question, and of these, 244 (80%) explained their views. Parents with views consistent with support for adolescent autonomy (n = 99) wanted to encourage responsible behaviour, protect children from ill-informed or bigoted parents, and respected confidentiality and individual rights. In contrast, 97 parents insisted on being involved in decision-making. They emphasised adult responsibility for a child's health and guidance, erosion of parental rights, and respect for cultural and moral values. Other parents (n = 48) wanted clearer legal definitions governing parental rights and responsibilities or hoped for joint decision-making. Parents resistant to adolescent autonomy would be less likely to consent to future HPV vaccination, (67%) than parents supporting this principle (89%; p < 0.001).
Conclusion: In the UK, the principle of adolescent autonomy is recognised and logically should include the right to HPV vaccination, but this may concern parents who would otherwise approve vaccination.
References
-
- Villa LL, Costa RR, Petta CA, Andrade R, Ault K, Giuliano A, Wheeler C, Koutsky L, Malm C, Lehtinen M. Prophylactic human papillomavirus (types 6,11,16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005;6:271–8. doi: 10.1016/S1470-2045(05)70101-7. - DOI - PubMed
-
- Brinkman JA, Caffrey AS, Muderspach LI, Roman LD, Kast WM. The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: consequences for clinical management. Eur J Gynaecol Oncol. 2005;XXVI:129–142. - PubMed
-
- Wright TC, Van Damme P, Schmitt H-J, Meheus A. HPV vaccine introduction in industrialized countries. Vaccine. 2006;24:S178–86. - PubMed
-
- Harper DM, Franco EL, Wheeler C, Ferris D, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, De Carvalho N. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet. 2004;364:1757–65. doi: 10.1016/S0140-6736(04)17398-4. - DOI - PubMed
-
- Advisory Committee on Immunization Practices . Provisional recommendations for the use of the quadrivalent HPV vaccine. Centers for Disease Control, Atlanta; http://www.cdc.gov/nip/recs/provisional_recs/hpv.pdf August 14, 2006.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
